Tiptoeing on Metastatic Adenocarcinoma of the Lung

Figure 3

CT and fused PET/CT imaging (axial). (a, b) Staging CT and fused PET/CT of the base of the skull to midthigh showing a FDG avid mass in the left lower lobe of the lung with adjacent left hilar lymphadenopathy. Max SUV 14.83. (c, d) Restaging CT and fused PET/CT of the full body approx. 4 months after initiation of chemotherapy showing reduction in size of FDG avid mass in the left lower lobe of the lung with adjacent left hilar lymphadenopathy.

(a)

(b)

(c)

(d)